BDBM50091858 CHEMBL440818::GGQPK-cyclic-(CVWTLPGFHC)-YSTGG-NH2

SMILES CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H]2CCCN2C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)NCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)CN)C(C)C)[C@@H](C)O

InChI Key InChIKey=BKESLFARDNPTHZ-JQHOUQQFSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50091858   

TargetErythropoietin receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50091858(CHEMBL440818 | GGQPK-cyclic-(CVWTLPGFHC)-YSTGG-NH2)
Affinity DataIC50:  5.00E+3nMAssay Description:Compound was evaluated for inhibition of [125I]-EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed